Total Funding
57
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
288204
Qron is a publicly-traded, preclinical biotechnology company that develops advanced cell-based solutions to combat neurological injuries.
- Jonah Meer: CEO
- Ido Merfeld: CO-FOUNDER, PRESIDENT, DIRECTOR
About the Company
Qron is a publicly-traded, preclinical biotechnology company that develops advanced cell-based solutions to combat neurological injuries. While they are laser-focused on traumatic brain injury (TBI), their technology could potentially treat a wide range of neurodegenerative diseases.
Their TBI treatment integrates proprietary, engineered
mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials, and a novel delivery system.
They believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients.
It was founded in 2016 and is headquartered in New York, New York.
